Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
2011
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
2008
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
2010
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
2011
Cardiac Care for Older Adults
2011
The safety of statins in clinical practice
2007
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
2009
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
2009
Drug Treatment of Hyperlipidemia in Women
2004
Vascular dementia
2015 Standout
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
2010
Low density lipoprotein cholesterol, statins and cardiovascular events: a meta–analysis
2006
Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia
1995
Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study
2005
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Stroke prevention, blood cholesterol, and statins
2004
The metabolic syndrome
2010 Standout
Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics
2004
Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta-Analysis
2009
Mild Cognitive Impairment
2011 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer
2007
Age and gender bias in statin trials
2001
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
2008
Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT–TIMI 22 Study
2006
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
2003
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Prevention of stroke and dementia with statins
2003
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Meta‐analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes
2004
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
2006
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2007
The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
2008
Design of a novel class of biphenyl CETP inhibitors
2010
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
2010
Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy
2010
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
2009
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
2004
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
2012
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
2006
Statin Use and Incident Frailty in Women Aged 65 Years or Older: Prospective Findings From the Women's Health Initiative Observational Study
2008
Impact of Systemic Hypertension on the Cardiovascular Benefits of Statin Therapy—A Meta-Analysis
2008
Statin Safety: A Systematic Review
2006
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease
2007
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
2008 StandoutNobel
Primary Prevention of Cardiovascular Disease with Statins in the Elderly
2014
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
2011
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
2009
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Alzheimer's Disease
2010 Standout
Parkinson's Disease
1998 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
New and emerging data from clinical trials of statins
2004
Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy
2005
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Statins and All-Cause Mortality in High-Risk Primary Prevention
2010
Safety of Aggressive Lipid Management
2007
Statin-Associated Myopathy
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Pleiotropic Effects of Statins
2010
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
2009
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)
2004
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
2013
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
2010
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
2012
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Alzheimer's disease: the cholesterol connection
2003
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Statins and the Risk of Colorectal Cancer
2005
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
2004
Statins: An essential component in the management of carotid artery disease
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease
2010
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
2005
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Mild cognitive impairment and cognitive impairment, no dementia: Part B, therapy
2007
Statin Therapy and the Risk of Intracerebral Hemorrhage
2012
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Pravastatin and the Development of Diabetes Mellitus
2001
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women
2008
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID Trial
2001
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
2011
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics
2008
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy
1995
Statins for the primary prevention of cardiovascular disease
2013
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population
2012
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Estrogen Increases Bone Marrow–Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation
2003
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
2010
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
Position Statement of the American Association for Geriatric Psychiatry Regarding Principles of Care for Patients With Dementia Resulting From Alzheimer Disease
2006
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Mild cognitive impairment
2005
Magnetic resonance spectroscopic study of parkinsonism related to boxing.
1995
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial
2003
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
2008
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
2006
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Works of Brian Sweeney being referenced
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
2002
The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
1999
Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings.
1993
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
PROTON SPECTROSCOPY OF THE BRAIN IN HIV-INFECTION - CORRELATION WITH CLINICAL, IMMUNOLOGICAL, AND MR-IMAGING FINDINGS
1993
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
2005